Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations

Asian Pac J Cancer Prev. 2014;15(21):9259-64. doi: 10.7314/apjcp.2014.15.21.9259.

Abstract

Background: Previous studies concerning the association between the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism with lung cancer in Asian populations have provided inconclusive findings.

Aim: A meta-analysis was performed to investigate a more reliable association between MTHFR C677T polymorphism and lung cancer in Asians.

Materials and methods: A comprehensive search was conducted to identify all case-control studies of MTHFR polymorphisms and lung cancer in Asia, using odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of any association.

Results: Meta-analysis results suggested that the MTHFR C677T polymorphism contributed to an increased lung cancer risk in Asian populations (for T vs C: OR=1.11, 95%CI=1.0-1.23; for CT vs CC: OR= 1.1, 95%CI= 0.95-1.2 ; for TT+CT vs CC: OR=1.13, 95%CI=1.0-1.30; for TT vs CC: OR=1.25, 95%CI=1.01-1.30; for TT vs CT+CC: OR=1.16, 95%CI=1.0-1.36).

Conclusions: MTHFR C677T polymorphism is significantly associated with lung cancer in Asians.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Asian People / genetics*
  • Case-Control Studies
  • Folic Acid / metabolism
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Lung Neoplasms / genetics*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Genetic
  • Risk Factors
  • Signal Transduction / genetics

Substances

  • Folic Acid
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)